This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Adaptive Biotechnologies Corporation. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Innovations of Peter J R Ebert
Introduction
Peter J R Ebert is an accomplished inventor based in Seattle, WA. He has made significant contributions to the field of biotechnology, particularly in the area of T cell receptors. His work has implications for cancer treatment and immunology.
Latest Patents
Ebert holds a patent for "Determining WT-1 specific T cells and WT-1 specific T cell receptors (TCRs)." This invention focuses on methods for identifying antigen-specific T cells and T cell receptors that specifically bind to the Wilms' tumor antigen-1 (WT1) protein. The patent also includes polynucleotides encoding the TCRs, engineered cells that express these TCRs, and methods for their production and application. He has 1 patent to his name.
Career Highlights
Peter J R Ebert is associated with Adaptive Biotechnologies Corporation, a company known for its innovative approaches in the field of immune-driven medicine. His work at the company has positioned him as a key figure in advancing therapeutic strategies for various diseases.
Collaborations
Ebert has collaborated with notable colleagues such as Joyce K Hu and Mark Klinger. These partnerships have further enhanced the research and development efforts in his field.
Conclusion
Peter J R Ebert's contributions to biotechnology and his innovative patent on T cell receptors highlight his role as a significant inventor in the industry. His work continues to pave the way for advancements in cancer treatment and immunology.